Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2008) 16 P265

ECE2008 Poster Presentations Endocrine disruptors (9 abstracts)

Clinical and laboratory symptoms of metabolic syndrome in women in climacteric period

Jolanta Mieczkowska , Wojciech Barud & Grazyna Orlicz-Szczesna


Medical University, Lublin, Poland.


The aim of the study was the analysis of dependencies between sex hormones and metabolic syndrome.

Forty-five women with metabolic syndrome and 49 healthy women were examined.

The diagnostic criteria of metabolic syndrome: waistline ≥80 cm, waistline/hips index WHI≥0.85 and also having 1 or 2 cardiovascular risk factors: glucose≥100 mg%, RR≥130/80, HDL< 50mg% and TG≥150 mg%.

The levels of estradiol (E2), testosterone (T), dehydroepiandrosterone sulphate (DHEA-S), sex hormone binding globulin (SHBG) were measured. Free testosterone index (FTI), free estradiol index (FE2I) and free testosterone (FT) were determined by means of a calculation method.

A significant difference between the group with metabolic syndrome (FTI-5.13±3.72, FE2I-517.28±539.69, SHBG-48.49±32.18 nmol/l) and the control group (FTI-3.04±1.65, FE2I-281.72±313.6, CRP-1.49±1.38 mg/dl, SHBG-61.28±30.89 nmol/l) concerned FTI(P<0.01), FE2I (P<0.05), SHBG (P<0.05).

There was a significant correlation of waistline with SHBG (r=−0.274), with FTI (r=0.324) and with FE2I (r=0.248) and WHI with SHBG (r=−0.239), with FTI (r=0.302), with FE2I (r=0.210) in women with metabolic syndrome.

The pathogenesis of metabolic syndrome in menopausal women is connected with bioavailability of sex hormones and binding proteins.

Article tools

My recent searches

No recent searches.